Skip to main content

Singhal Priya's Form 4 filing

Biogen Inc. (BIIB) · filed Mar 30, 2023

Accession no.
0001127602-23-011661
Filed
Mar 30, 2023
Trade date
Mar 28, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $153.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Singhal PriyaCIK 0001769608Officer (Head of Development)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 28, 2023Common StockSSaleDisposed−568$270.06−$153,394.082,842.39Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)